Beta Bionics (BBNX) Gains from Investment Securities (2023 - 2026)

Beta Bionics has disclosed Gains from Investment Securities across 4 years of filings, most recently posting $1000.0 for Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at $1000.0, down 99.99% year-over-year; the trailing twelve-month figure through Mar 2026 was -$12.4 million (down 251.16% YoY), and the FY2025 annual result was $6.5 million, up 13.86% from the prior year.
• Gains from Investment Securities came in at $1000.0 for Q1 2026 at Beta Bionics, up from -$12.4 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $8.2 million in Q1 2025 to a low of -$12.4 million in Q4 2025.
• The 4-year median for Gains from Investment Securities is $156340.0 (2025), against an average of $949533.0.
• Peak annual rise in Gains from Investment Securities reached 137.31% in 2025, while the deepest fall reached 1241900.0% in 2025.
• Beta Bionics' Gains from Investment Securities stood at $5.2 million in 2023, then sank by 100.02% to -$1000.0 in 2024, then slumped by 1241900.0% to -$12.4 million in 2025, then surged by 100.01% to $1000.0 in 2026.
• The last three Gains from Investment Securities figures came in at $1000.0 (Q1 2026), -$12.4 million (Q4 2025), and $156340.0 (Q3 2025), per Business Quant data.